High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to avapritinib, a drug already approved by the US FDA. The corresponding study was published ...

Partners for Kids has initiated Santa Barbara County’s first Pediatric Concurrent Care Collaborative designed to offer comprehensive, compassionate, and coordinated care to seriously ill children from ...

In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center are launching a first-of-its-kind clinical trial to ...

Iopofosine-131 received rare pediatric drug designation for treating relapsed or refractory pediatric high-grade glioma, highlighting its potential in addressing aggressive pediatric brain cancers.

Boston, MA – A groundbreaking study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights ...

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, often resistant to treatment in advanced cases. Researchers have identified thiostrepton (TST), a ribosome-targeting ...

Pediatric readiness should system strategy to ensure consistent emergency care quality across all Inova hospitals in Northern Virginia.

The completion of multiple national pediatric precision oncology platform trials and the incorporation of standardized molecular profiling into the diagnostic care of pediatric and young adult ...

The 200mg single-dose prefilled autoinjector allows pediatric patients to receive LN treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab), ...